Form 4 Tracker
Steven P. Coen

Chief Financial Officer · 4 filings · Latest: Apr 16, 2026

Ginkgo Bioworks Holdings, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
DNA
Steven P. CoenChief Financial OfficerApr 17, 2026
Sale
$7.95324$2.6K50,268
DNA
Steven P. CoenChief Financial OfficerApr 16, 2026
Option Exercise
74350,592
DNA
Coen Steven P.Apr 17, 2026
Proposed Sale
$7.95324$2.6K
DNA
Steven P. CoenChief Financial OfficerApr 13, 2026
Sale
$6.4133,171$212.8K49,849
DNA
Steven P. CoenChief Financial OfficerApr 10, 2026
Option Exercise
73,92183,020
DNA
Coen Steven P.Apr 13, 2026
Proposed Sale
$6.4133,171$212.8K
DNA
Steven P. CoenChief Financial OfficerMar 16, 2026
Sale
$6.74708$4.8K9,099
DNA
Steven P. CoenChief Financial OfficerMar 13, 2026
Option Exercise
1,4869,807
DNA
Coen Steven P.Mar 16, 2026
Proposed Sale
$6.74708$4.8K
DNA
Steven P. CoenChief Financial OfficerJan 20, 2026
Sale
$8.92972$8.7K8,321
DNA
Steven P. CoenChief Financial OfficerJan 16, 2026
Option Exercise
1,8059,293
DNA
Coen Steven P.Jan 20, 2026
Proposed Sale
$8.92972$8.7K
DNA
Coen Steven P.Dec 15, 2025
Proposed Sale
$8.89736$6.5K
DNA
Coen Steven P.Oct 21, 2025
Proposed Sale
$15.005,609$84.1K
DNA
Coen Steven P.Oct 21, 2025
Proposed Sale
$13.651,312$17.9K